Institute For Cancer Research
67% goes to programs $6 to raise $100 Strong reserves Growing revenue
Institute For Cancer Research is a 501(c)(3) organization based in Philadelphia, Pennsylvania, registered in 1944, with $98,007,791 in FY2023 revenue. CharityIndex grades it A, and it directs about 67% of spending to programs.
3509 N Broad St Boyer Pav 225, Philadelphia, PA, 19140 EIN 23-6296135 Since 1944
Revenue (FY2023)
$98.0M
▼ 0.8% vs prior year
Medical Research median: $217K
Expenses (FY2023)
$97.2M
Net assets
$115.6M
Employees
749
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
A
BProgram efficiency40% of the rating67% to programs · $6 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Institute For Cancer Research: 67% to programs · $6 to raise $100 earns a B on this criterion. See the exact thresholds →
AFinancial health25% of the rating14 mo reserves · +1% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Institute For Cancer Research: 14 mo reserves · +1% margin earns a A on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Institute For Cancer Research: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
A+Transparency10% of the rating5 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Institute For Cancer Research: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
To prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention and compassionate care.
What they do
The research facilities have been structured to fulfill the needs of the multi-disciplinary research programs at fox chase cancer center. the facilities have been designed to enhance ongoing research by supplying information, reagents, and technical expertise that are not readily available to the individual investigator.
Contact & location
- Address
- 3509 N Broad St Boyer Pav 225, Philadelphia, PA, 19140
- City
- Philadelphia
- State
- Pennsylvania
- Category
- Medical Research
- Subcategory
- Cancer Research
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $63.9M (FY2013) to $98.0M (FY2023) across 10 reported years.
Financial snapshot
Financial health & position (FY2023)
Liabilities $67.1MNet assets $115.6M
Operating margin
0.9%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$182.7M
Total liabilities
$67.1M
Net assets
$115.6M
Salaries & benefits
$66.7M
69% of expenses
Board members
15
13 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $98,007,791▼0.8% | $97,174,266▲7.4% | $115,595,344▲6.6% | $182,653,136▲11.1% | 990 |
| 2022 | $98,782,288▲0.6% | $90,482,128▲0.7% | $108,422,889▲10.3% | $164,344,413▲11.3% | 990 |
| 2021 | $98,184,142▲18.9% | $89,809,102▲8.5% | $98,278,742▼4.3% | $147,654,259▼0.3% | 990 |
| 2020 | $82,576,402▼2.3% | $82,749,706▼0.7% | $102,746,584▲9.1% | $148,137,241▲6.9% | 990 |
| 2019 | $84,512,991▲1.8% | $83,337,665▲0.3% | $94,133,575▼5.0% | $138,576,828▼2.9% | 990 |
| 2018 | $83,025,248▼15.0% | $83,115,501▲3.4% | $99,052,486▼0.2% | $142,695,790▲4.8% | 990 |
| 2017 | $97,662,344▲27.8% | $80,390,149▲2.5% | $99,289,839▼5.6% | $136,111,873▼4.2% | 990 |
| 2016 | $76,432,160▼9.9% | $78,440,750▲8.1% | $105,142,915▲1.9% | $142,028,464▲8.1% | 990 |
| 2015 | $84,834,617▲32.8% | $72,562,797▼0.2% | $103,178,516▲62.7% | $131,419,713▼1.9% | 990 |
| 2013 | $63,899,594 | $72,702,230▼5.6% | $63,413,447▲0.2% | $133,913,499▲7.8% | 990 |
| 2012 | — | $77,036,863▲159% | $63,286,049▼23.1% | $124,201,692▼8.8% | 990 |
| 2011 | — | $29,742,314▼7.8% | $82,349,630▲270% | $136,225,031▲71.2% | 990 |
| 2010 | — | $32,241,484▼3.9% | $22,277,809▼19.7% | $79,553,598▼4.5% | 990 |
| 2009 | — | $33,541,699 | $27,759,717 | $83,336,426 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2023)
Highest-paid: Jonathan Chernoff — $611,776 (0.63% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Jonathan Chernoff | Cancer Center Director | 49 | $611,776 |
| David Wiest | Chief Scientific Officer | 50 | $548,379 |
| Michael Hall | Professor | 50 | $499,544 |
| Elizabeth Plimack | Professor | 50 | $486,255 |
| Efrat Dotan | Associate Professor / Md | 50 | $363,566 |
| Shawn Paul Kleitz | Chief Development Officer | 50 | $353,680 |
| Carolyn Fang | Professor | 50 | $328,852 |
| Mary Daly | Professor | 50 | $328,504 |
| Amy Goldberg | Director | 1 | — |
| Carl Sottosanti | Director | 1 | — |
| Chip W Marshall III | Director/chair (from 2/21/2024) | 1 | — |
| Christopher Mcnichol | Director/vice Chair | 1 | — |
| David Marshall | Director | 1 | — |
| Dr Donald Morel | Director | 1 | — |
| Dr Robert Uzzo | President & Ceo | 1 | — |
| Dr Solomon Luo | Director | 1 | — |
| Edward Glickman | Director | 1 | — |
| Jarred Matchett | Treasurer & Cfo | 1 | — |
| Jerome Maddox | Secretary | 1 | — |
| John Ryan | Asst Secretary | 1 | — |
Top vendors & contractors (FY2023)
| Contractor | Services | Paid |
|---|---|---|
| American Oncologic Hospital | Purchased Services | $6,160,363 |
| Temple University Health System | Purchased Services | $3,549,110 |
| Southampton Window Cleaning & Janitorial | Purchased Services | $617,685 |
| West Chester Mechanical Contractor | Purchased Services | $240,788 |
| Jan Pro of Philadelphia | Purchased Services | $188,267 |
Grants received · $301.7M total
155 grants to Institute For Cancer Research totaling $301.7M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $2,000,000 |
| American Cancer Society Inc | Extramural research | 2024 | $1,381,000 |
| The V Foundation | Cancer research | 2024 | $600,000 |
| Entertainment Industry Foundation | General program | 2024 | $396,800 |
| Entertainment Industry Foundation | General program | 2024 | $396,800 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $105,000 |
| American Online Giving Foundation Inc | General support | 2024 | $51,727 |
| Charities Aid Foundation America | Charitable donation | 2024 | $23,813 |
| University of Miami | Research | 2024 | $14,355 |
| T Rowe Price Program For Charitable Giving Inc | Multiple | 2024 | $13,000 |
| The Albertsons Companies Foundation | Hunger | 2024 | $10,000 |
| Paypal Charitable Giving Fund | General support | 2024 | $8,774 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $7,500 |
| Philadelphia Foundation | Medical equipment | 2024 | $6,115 |
| The American Oncologic Hospital | Research | 2023 | $37,651,131 |
Grants made · $1.1M in FY2023
2 grants totaling $1.1M in FY2023. All grants made by Institute For Cancer Research →
| Recipient | Purpose | Amount |
|---|---|---|
| Fox Chase Cancer Center Medical Group Inc | General support | $583,894 |
| The American Oncologic Hospital | General support | $529,974 |
Similar organizations in Medical Research
Medical Research
The Wistar Institute of Anatomy and Biology
Philadelphia, PA
$93.1M
Aannual revenue
Medical Research
Philadelphia Fight
Philadelphia, PA
$60.6M
Aannual revenue
Medical Research
American Association For Cancer Research
Philadelphia, PA
$137.4M
Aannual revenue
Medical Research
Every Cure Inc
Philadelphia, PA
$54.5M
Bannual revenue
Medical Research
Greater Delaware Valley Society of Transplant Surgeons
Philadelphia, PA
$152.9M
A+annual revenue
Medical Research
Transcelerate Biopharma Inc
West Conshohocken, PA
$38.6M
Bannual revenue
Medical Research
Nsabp Foundation Inc
Pittsburgh, PA
$37.6M
Bannual revenue
Medical Research
Centre County Cancer Center
State College, PA
$35.4M
C+annual revenue
Medical Research
Nrg Oncology Foundation Inc
Pittsburgh, PA
$33.9M
C+annual revenue
Medical Research
Wills Eye Ophthalmology Clinic Inc
Philadelphia, PA
$32.0M
Dannual revenue
Compare Institute For Cancer Research
Frequently asked questions
- Is Institute For Cancer Research a legitimate nonprofit?
- Yes. Institute For Cancer Research is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 23-6296135, based in Philadelphia, Pennsylvania. Donations are tax-deductible.
- What is Institute For Cancer Research's EIN?
- Institute For Cancer Research's Employer Identification Number (EIN) is 23-6296135.
- How much revenue does Institute For Cancer Research report?
- Institute For Cancer Research reported $98,007,791 in total revenue on its fiscal year 2023 IRS Form 990 filing.
- How much of Institute For Cancer Research's spending goes to programs?
- Institute For Cancer Research spends about 67% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does Institute For Cancer Research have?
- CharityIndex grades Institute For Cancer Research A, based on program efficiency and fundraising cost.
- How much does Institute For Cancer Research's highest-paid employee make?
- The highest reported compensation on Institute For Cancer Research's latest Form 990 is $611,776, paid to Jonathan Chernoff (Cancer Center Director).
More nonprofits in Philadelphia
Explore more
Data for Institute For Cancer Research (EIN 23-6296135) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.